Percutaneous Ethanol Injection vs Reoperation for Locally Recurrent Papillary Thyroid Cancer

Fontenot, Tatyana E.; Deniwar, Ahmed; Bhatia, Parisha; Al‐Qurayshi, Zaid; Randolph, Gregory W.; Kandil, Emad

doi:10.1001/jamaoto.2015.0596

Cited by 53 publications

(37 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…53–58 In addition, high-intensity focused ultrasound has been used for ablation of benign thyroid nodules and may have potential for use in DTC. 59,60 However, these techniques are outside the scope of this article and should only be used as an alternative to EBRT in highly selected cases.…”

Section: Recommendationsmentioning

confidence: 99%

“…[50][51][52] Several recent publications show promise for using other focal therapies such as radiofrequency ablation or percutaneous ethanol injection for locoregional recurrence of DTC. [53][54][55][56][57][58] In addition, high-intensity focused ultrasound has been used for ablation of benign thyroid nodules and may have potential for use in DTC. 59,60 However, these techniques are outside the scope of this article and should only be used as an alternative to EBRT in highly selected cases.…”

Section: Combination Of External-beam Radiotherapy With Other Therapiesmentioning

confidence: 99%

See 1 more Smart Citation

External‐beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society

Kiess¹,

Agrawal²,

Brierley

et al. 2015

Head & Neck

Self Cite

View full text Add to dashboard Cite

The use of external-beam radiotherapy (EBRT) in differentiated thyroid cancer (DTC) is debated because of a lack of prospective clinical data, but recent retrospective studies have reported benefits in selected patients. The Endocrine Surgery Committee of the American Head and Neck Society provides 4 recommendations regarding EBRT for locoregional control in DTC, based on review of literature and expert opinion of the authors. (1) EBRT is recommended for patients with gross residual or unresectable locoregional disease, except for patients <45 years old with limited gross disease that is radioactive iodine (RAI)-avid. (2) EBRT should not be routinely used as adjuvant therapy after complete resection of gross disease. (3) After complete resection, EBRT may be considered in select patients >45 years old with high likelihood of microscopic residual disease and low likelihood of responding to RAI. (4) Cervical lymph node involvement alone should not be an indication for adjuvant EBRT.

show abstract

Section: Recommendationsmentioning

confidence: 99%

Section: Combination Of External-beam Radiotherapy With Other Therapiesmentioning

confidence: 99%

External‐beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society

Kiess¹,

Agrawal²,

Brierley

et al. 2015

Head & Neck

Self Cite

View full text Add to dashboard Cite

show abstract

“…Meta‐analysis of the results of percutaneous ethanol versus surgery for locally recurrent papillary thyroid cancer suggests that surgery is successful in 95% of cases versus 88% with percutaneous ethanol . As a result, percutaneous ethanol is supported as an adjunct to surgery for recurrent differentiated thyroid cancer by the Thyroid Cancer Care Collaborative .…”

Section: Malignant Thyroid Diseasementioning

confidence: 99%

Image‐guided chemical and thermal ablations for thyroid disease: Review of efficacy and complications

et al. 2018

View full text Add to dashboard Cite

Image-guided ablation of thyroid disease is increasingly being commonly reported. Techniques including ethanol injection and thermal ablation using radio-frequency, laser, and microwave devices have been described. Minimally invasive approaches to the management of benign cystic, solid, and functional thyroid nodules as well as both primary and recurrent thyroid malignancy have been reported. The purpose of this article is to review the current evidence relating to image-guided ablation of thyroid disease with a focus on clinical outcomes and complication rates for patients treated with this minimally invasive approach.

show abstract

“…PEI offers distinct advantages over re-operation because it avoids most of the complications of surgical intervention (4). The most common complications after PEI are temporary hoarseness and local transient pain (5).…”

Section: Introductionmentioning

confidence: 99%

Horner Syndrome After Percutaneous Ethanol Injection For Treatment Of Metastatic Papillary Thyroid Carcinoma: Case Report And Review Of The Literature

Ahmed

Sanfield

Freitas

2017

AACE Clinical Case Reports

View full text Add to dashboard Cite

Percutaneous Ethanol Injection vs Reoperation for Locally Recurrent Papillary Thyroid Cancer

Cited by 53 publications

References 35 publications

External‐beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society

External‐beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society

Image‐guided chemical and thermal ablations for thyroid disease: Review of efficacy and complications

Horner Syndrome After Percutaneous Ethanol Injection For Treatment Of Metastatic Papillary Thyroid Carcinoma: Case Report And Review Of The Literature

Contact Info

Product

Resources

About